Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
2022年6月13日 - 7:11PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE
ACT OF 1934
For the month of June 2022
Commission File Number: 001-40488
Molecular Partners AG
(Translation of registrant's
name into English)
Wagistrasse 14
8952 Zurich-Schlieren
Switzerland
(Address of principal
executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
[ X ] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.
|
|
Molecular Partners AG |
|
|
(Registrant) |
|
|
|
|
|
|
Date: June 13, 2022 |
|
/s/ PATRICK AMSTUTZ |
|
|
Patrick Amstutz |
|
|
Chief Executive Officer |
|
|
|
Molecular Partners (CE) (USOTC:MLLCF)
過去 株価チャート
から 5 2024 まで 6 2024
Molecular Partners (CE) (USOTC:MLLCF)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Molecular Partners AG (CE) (その他OTC): 0 recent articles
その他のMolecular Partners Agニュース記事